Mskcc Renal Cell Carcinoma Risk Stratification

The renal cell carcinoma tool consists of the motzer score resulted from the memorial sloan kettering cancer center mskcc study and the extended version created by mekhail.

Mskcc renal cell carcinoma risk stratification.

The two scores of 5 respectively 7 items are the only clinical judgment tools that address survival of patients with metastatic renal cell carcinoma. Who can use this tool. Our renal cell carcinoma nomogram is an online tool that can be used to predict the likelihood that a patient s kidney cancer will not recur at five years after surgery following a new diagnosis. It is based on the 670 patient original 1999 study by robert j motzer md at the memorial sloan kettering cancer center mskcc and is the most widely recognized prognostic algorithm for rcc.

This health tool determines survival in the case of patient with metastatic renal cell carcinoma based on their clinical and laboratory data. Motzer md is a medical oncologist at memorial sloan kettering cancer center. If you are a patient we recommend that you use this tool in consultation with your. It is appropriate for patients who have undergone either radical nephrectomy complete surgical removal of a kidney or partial nephrectomy surgical removal of the cancerous.

This nomogram was designed to be used by physicians and people with renal cell carcinoma.